INBS vs. IBRX

Last updated Apr 1, 2026

Compare and contrast key facts about Intelligent Bio Solutions Inc. (INBS) and ImmunityBio, Inc. (IBRX).

Performance

INBS vs. IBRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intelligent Bio Solutions Inc. (INBS) and ImmunityBio, Inc. (IBRX). The values are adjusted to include any dividend payments, if applicable.

INBS vs. IBRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
INBS Intelligent Bio Solutions Inc.	-64.90%	-31.93%	-65.47%	-91.55%	-86.07%	-80.61%	-32.85%
IBRX ImmunityBio, Inc.	287.37%	-22.66%	-49.00%	-0.99%	-16.61%	-54.39%	-24.30%

Fundamentals

Market Cap INBS : $3.18M IBRX : $7.59B
EPS INBS : -$14.52 IBRX : -$0.37
PS Ratio INBS : 0.73 IBRX : 63.74
Total Revenue (TTM) INBS : $3.58M IBRX : $113.29M
Gross Profit (TTM) INBS : $1.65M IBRX : $112.54M
EBITDA (TTM) INBS : -$10.62M IBRX : -$257.20M

Returns By Period

In the year-to-date period, INBS achieves a -64.90% return, which is significantly lower than IBRX's 287.37% return.

INBS

• 1D: 16.55%
• 1M: -25.67%
• YTD: -64.90%
• 6M: -67.21%
• 1Y: -76.77%
• 3Y*: -78.74%
• 5Y*: -81.05%
• 10Y*: —

IBRX

• 1D: 15.17%
• 1M: -21.57%
• YTD: 287.37%
• 6M: 211.79%
• 1Y: 154.82%
• 3Y*: 61.53%
• 5Y*: -19.29%
• 10Y*: -1.17%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

INBS vs. IBRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INBS

INBS Risk / Return Rank: 16
INBS Sharpe Ratio Rank: 21
INBS Sortino Ratio Rank: 20
INBS Omega Ratio Rank: 21
INBS Calmar Ratio Rank: 8
INBS Martin Ratio Rank: 9

IBRX

IBRX Risk / Return Rank: 84
IBRX Sharpe Ratio Rank: 84
IBRX Sortino Ratio Rank: 87
IBRX Omega Ratio Rank: 83
IBRX Calmar Ratio Rank: 88
IBRX Martin Ratio Rank: 79

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INBS vs. IBRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Intelligent Bio Solutions Inc. (INBS) and ImmunityBio, Inc. (IBRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	INBS	IBRX	Difference
Sharpe ratio Return per unit of total volatility	-0.45	1.44	-1.88
Sortino ratio Return per unit of downside risk	-0.49	2.54	-3.03
Omega ratio Gain probability vs. loss probability	0.94	1.31	-0.36
Calmar ratio Return relative to maximum drawdown	-0.89	3.40	-4.29
Martin ratio Return relative to average drawdown	-1.54	5.58	-7.12
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

INBS vs. IBRX - Sharpe Ratio Comparison

The current INBS Sharpe Ratio is -0.45, which is lower than the IBRX Sharpe Ratio of 1.44. The chart below compares the historical Sharpe Ratios of INBS and IBRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	INBS	IBRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.45	1.44	-1.88
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.38	-0.17	-0.21
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.01	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.39	-0.12	-0.27

Correlation

The correlation between INBS and IBRX is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

INBS vs. IBRX - Dividend Comparison

Neither INBS nor IBRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

INBS vs. IBRX - Drawdown Comparison

The maximum INBS drawdown since its inception was -99.99%, roughly equal to the maximum IBRX drawdown of -97.14%. Use the drawdown chart below to compare losses from any high point for INBS and IBRX.

Drawdown Indicators

	INBS	IBRX	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-97.14%	-2.85%
Max Drawdown (1Y) Largest decline over 1 year	-87.24%	-42.44%	-44.80%
Max Drawdown (5Y) Largest decline over 5 years	-99.98%	-94.40%	-5.58%
Max Drawdown (10Y) Largest decline over 10 years	—	-97.03%	—
Current Drawdown Current decline from peak	-99.99%	-81.85%	-18.14%
Average Drawdown Average peak-to-trough decline	-91.26%	-83.94%	-7.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	50.60%	25.86%	+24.74%

Volatility

INBS vs. IBRX - Volatility Comparison

The current volatility for Intelligent Bio Solutions Inc. (INBS) is 25.13%, while ImmunityBio, Inc. (IBRX) has a volatility of 38.29%. This indicates that INBS experiences smaller price fluctuations and is considered to be less risky than IBRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	INBS	IBRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.13%	38.29%	-13.16%
Volatility (6M) Calculated over the trailing 6-month period	122.87%	87.83%	+35.04%
Volatility (1Y) Calculated over the trailing 1-year period	172.12%	108.55%	+63.57%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	215.77%	113.60%	+102.17%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	211.54%	111.61%	+99.93%

Financials